Seeing Is Believing

Currently out of the existing stock ratings of Brandon Folkes, 130 are a BUY (86.09%), 1 are a SELL (0.66%), 20 are a HOLD (13.25%).
Analyst Brandon Folkes, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 34.63% that have a potential upside of 30.42% achieved within 256 days.
Brandon Folkes’s has documented 302 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on COLL, Collegium Pharmaceutical at 09-Jan-2026.
Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for OMER (OMEROS) at 11/14/2024. The price target of $9 was fulfilled within 8 days with a profit of $2.05 (29.5%) receiving and performance score of 36.87.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$6
$0.41 (7.33%)
$8
3 years 10 months 17 days ago
(25-Feb-2022)
1/4 (25%)
$2.17 (44.83%)
281
Hold
Since 14-Feb-2022
$5
$-0.59 (-10.55%)
3 years 10 months 28 days ago
(14-Feb-2022)
0/1 (0%)
$-0.56 (-10.07%)
Hold
Since 05-Nov-2021
$4.5
$-1.09 (-19.50%)
3 years 11 months 21 days ago
(21-Jan-2022)
4/4 (100%)
$1.14 (33.93%)
167
Buy
Since 06-May-2021
$6.25
$0.66 (11.81%)
$5
4 years 8 months 5 days ago
(06-May-2021)
1/2 (50%)
$3.07 (96.54%)
287
Buy
$8
$2.41 (43.11%)
6 years 1 months 29 days ago
(13-Nov-2019)
1/2 (50%)
$2.26 (36.00%)
1683
Which stock is Brandon Folkes is most bullish on?
Which stock is Brandon Folkes is most reserved on?
What Year was the first public recommendation made by Brandon Folkes?